Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation is a research paper published in Cell Reports Medicine (2022). On theSindex it has a DataRank of 0.584. It has been cited 48 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.584
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Cleveland Clinic
Grant: UL1-RR024989
National Institutes of Health
Grant: K99HL138272
National Institute on Aging
Grant: R01AG076448
National Institute on Aging
Grant: P01HL158502
National Institute on Aging
Grant: R01AG066707
National Institute on Aging
Grant: R01-HL111314
National Institute on Aging
Grant: U01AG073323
American Heart Association Inc
Grant: 18SFRN34170013
American Heart Association Inc
Grant: 18SFRN34110067
American Heart Association Inc
Grant: 18SFRN34170442
National Institutes of Health
Grant: 2R01HL111314-05
Functional Genomics of Atrial Fibrillation
National Institutes of Health
Grant: 5R01AG076448-03
TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease
National Institutes of Health
Grant: 5R00HL138272-03
An individualized network medicine infrastructure for precision cardio-oncology
National Institutes of Health
Grant: 5UL1RR024989-05
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA
National Institutes of Health
Grant: 5U01AG073323-05
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
National Institutes of Health
Grant: 5R01AG066707-04
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease
National Institutes of Health
Grant: 1P01HL158502-01A1
Atrial Fibrillation Post-GWAS: Mechanisms to Treatment
NCRR NIH HHS
Grant: UL1 RR024989
NCATS NIH HHS
Grant: UL1 TR002548
NHLBI NIH HHS
Grant: R00 HL138272
NHLBI NIH HHS
Grant: R01 HL090620
NCATS NIH HHS
Grant: UL1 TR001422
Howard Hughes Medical Institute
Grant: GT14941
NHLBI NIH HHS
Grant: R01 HL111314
FWCI
3.37
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals